Show simple item record

dc.contributor.authorLo Gullo, Roberto
dc.contributor.authorSevilimedu, Varadan
dc.contributor.authorBaltzer, Pascal
dc.contributor.authorLe Bihan, Denis
dc.contributor.authorCamps-Herrero, Julia
dc.contributor.authorClauser, Paola
dc.contributor.authorGilbert, Fiona J
dc.contributor.authorIima, Mami
dc.contributor.authorMann, Ritse M
dc.contributor.authorPartridge, Savannah C
dc.contributor.authorPatterson, Andrew
dc.contributor.authorSigmund, Eric E
dc.contributor.authorThakur, Sunitha
dc.contributor.authorThibault, Fabienne E
dc.contributor.authorMartincich, Laura
dc.contributor.authorPinker, Katja
dc.contributor.authorEUSOBI International Breast Diffusion-Weighted Imaging working group
dc.date.accessioned2022-06-07T08:15:53Z
dc.date.available2022-06-07T08:15:53Z
dc.date.issued2022-10
dc.identifier.issn0938-7994
dc.identifier.other35507050
dc.identifier.otherPMC9064723
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/337816
dc.description.abstractOBJECTIVES: To perform a survey among all European Society of Breast Imaging (EUSOBI) radiologist members to gather representative data regarding the clinical use of breast DWI. METHODS: An online questionnaire was developed by two board-certified radiologists, reviewed by the EUSOBI board and committees, and finally distributed among EUSOBI active and associated (not based in Europe) radiologist members. The questionnaire included 20 questions pertaining to technical preferences (acquisition time, magnet strength, breast coils, number of b values), clinical indications, imaging evaluation, and reporting. Data were analyzed using descriptive statistics, the Chi-square test of independence, and Fisher's exact test. RESULTS: Of 1411 EUSOBI radiologist members, 275/1411 (19.5%) responded. Most (222/275, 81%) reported using DWI as part of their routine protocol. Common indications for DWI include lesion characterization (using an ADC threshold of 1.2-1.3 × 10-3 mm2/s) and prediction of response to chemotherapy. Members most commonly acquire two separate b values (114/217, 53%), with b value = 800 s/mm2 being the preferred value for appraisal among those acquiring more than two b values (71/171, 42%). Most did not use synthetic b values (169/217, 78%). While most mention hindered diffusion in the MRI report (161/213, 76%), only 142/217 (57%) report ADC values. CONCLUSION: The utilization of DWI in clinical practice among EUSOBI radiologists who responded to the survey is generally in line with international recommendations, with the main application being the differentiation of benign and malignant enhancing lesions, treatment response assessment, and prediction of response to chemotherapy. Report integration of qualitative and quantitative DWI data is not uniform. KEY POINTS: • Clinical performance of breast DWI is in good agreement with the current recommendations of the EUSOBI International Breast DWI working group. • Breast DWI applications in clinical practice include the differentiation of benign and malignant enhancing, treatment response assessment, and prediction of response to chemotherapy. • Report integration of DWI results is not uniform.
dc.languageeng
dc.publisherSpringer Science and Business Media LLC
dc.sourcenlmid: 9114774
dc.sourceessn: 1432-1084
dc.titleA survey by the European Society of Breast Imaging on the implementation of breast diffusion-weighted imaging in clinical practice.
dc.typeArticle
dc.date.updated2022-06-07T08:15:53Z
prism.publicationNameEur Radiol
dc.identifier.doi10.17863/CAM.85225
dcterms.dateAccepted2022-04-21
rioxxterms.versionofrecord10.1007/s00330-022-08833-0
rioxxterms.versionVoR
dc.contributor.orcidPinker, Katja [0000-0002-2722-7331]
dc.identifier.eissn1432-1084
cam.issuedOnline2022-05-04


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record